Modeling ovarian cancer chemoresistance: establishment of murine ID8 sublines and elucidation of adaptive mechanisms

Shanzhou Xie, Shiqiang Luo, Aozhen Bi, Lizhou Shi, Ying Zhang, Fuqiang Yin, Xia Liu · 2026

Read Modeling ovarian cancer chemoresistance: establishment of murine ID8 sublines and elucidation of adaptive mechanisms by Shanzhou Xie, Shiqiang Luo, Aozhen Bi, Lizhou Shi, Ying Zhang, Fuqiang Yin, Xia Liu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13612348.txt.

Description

Shanzhou Xie and six colleagues build, published in 2026, two mouse ovarian cancer cell lines that resist standard chemotherapy. Resistance to platinum and taxane drugs is a main reason ovarian cancer treatment fails. The team exposed a mouse cancer line to rising drug doses in pulses. One subline learned to resist paclitaxel, the other carboplatin. Both also resisted the other drug to a degree. They formed colonies better and shrugged off the cell-cycle arrest and death the drugs normally cause. Drug levels inside the resistant cells ran lower.

The cells also held their stress chemistry lower and rewired key proteins. A drug pump that ejects medicine was turned up. Survival signals stayed on, while the proteins that execute cell death were muted. A brake on the cell's power-plant splitting was also reduced. The authors offer both lines as shared tools for hunting ways to beat resistance.

Catalog record

CREATORShanzhou Xie, Shiqiang Luo, Aozhen Bi, Lizhou Shi, Ying Zhang, Fuqiang Yin, Xia Liu
YEAR2026
COLLECTIONPAPERS
FORMATTXT
FILE SIZE46 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC13612348

Browse the full library · About the Tower of Babel